Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Qiagen N.V. Common Shares
(NY:
QGEN
)
44.16
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,691
Open
44.16
Bid (Size)
43.83 (400)
Ask (Size)
43.88 (400)
Prev. Close
44.16
Today's Range
44.16 - 44.16
52wk Range
37.63 - 51.88
Shares Outstanding
227,985,334
Dividend Yield
0.57%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
November 04, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions
November 04, 2025
From
QIAGEN N.V.
Via
Business Wire
Performance
YTD
-0.8%
-0.8%
1 Month
-6.0%
-6.0%
3 Month
-11.6%
-11.6%
6 Month
+4.7%
+4.7%
1 Year
+1.2%
+1.2%
More News
Read More
Earnings Scheduled For November 4, 2025
November 04, 2025
Via
Benzinga
Earnings Scheduled For August 5, 2025
August 05, 2025
Via
Benzinga
A Look at Qiagen's Upcoming Earnings Report
August 04, 2025
Via
Benzinga
QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025
October 30, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing
October 28, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. (NYSE:QGEN) Passes the Caviar Cruise Quality Investment Screen
October 18, 2025
Via
Chartmill
QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast
October 13, 2025
From
QIAGEN N.V.
Via
Business Wire
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
October 01, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio
September 10, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing
September 02, 2025
From
QIAGEN N.V.
Via
Business Wire
DoorDash To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday
August 07, 2025
Via
Benzinga
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
August 05, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels
July 22, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. (NYSE:QGEN) - A Strong Technical Setup for Breakout Investors
July 21, 2025
Via
Chartmill
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast
July 08, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
June 26, 2025
From
QIAGEN N.V..
Via
Business Wire
QIAGEN N.V. (NYSE:QGEN) – A Quality Stock Worth Considering
June 26, 2025
Via
Chartmill
QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership
June 18, 2025
From
QIAGEN N.V.
Via
Business Wire
Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism
June 16, 2025
Via
Stocktwits
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
June 15, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships
June 02, 2025
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. (NYSE:QGEN) – A Quality Stock with Strong Fundamentals
June 02, 2025
Via
Chartmill
QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions
May 22, 2025
From
QIAGEN N.V.
Via
Business Wire
Frequently Asked Questions
Is Qiagen N.V. Common Shares publicly traded?
Yes, Qiagen N.V. Common Shares is publicly traded.
What exchange does Qiagen N.V. Common Shares trade on?
Qiagen N.V. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Qiagen N.V. Common Shares?
The ticker symbol for Qiagen N.V. Common Shares is QGEN on the New York Stock Exchange
What is the current price of Qiagen N.V. Common Shares?
The current price of Qiagen N.V. Common Shares is 44.16
When was Qiagen N.V. Common Shares last traded?
The last trade of Qiagen N.V. Common Shares was at 11/04/25 07:00 PM ET
What is the market capitalization of Qiagen N.V. Common Shares?
The market capitalization of Qiagen N.V. Common Shares is 10.07B
How many shares of Qiagen N.V. Common Shares are outstanding?
Qiagen N.V. Common Shares has 10B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.